Future of Diagnostics: Point of Care Market Set to Cross $106 Billion by 2033 | Key Players, M&A Trends & Future Growth Drivers

DataM Intelligence has released a new research report titled "Point of Care Diagnostics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Point of Care Diagnostics market.

The Point of Care Diagnostics market is poised for robust expansion, growing from US$ 44.72 billion in 2024 to an estimated US$ 106.35 billion by 2033, reflecting a strong CAGR of 10.7% during the 2025-2033 forecast period driven by accelerating demand for rapid, decentralized healthcare solutions and continuous technological innovation.

✦ Future growth in the Point of Care Diagnostics market will be fueled by the rising need for rapid and real-time diagnostic solutions across decentralized healthcare settings.

✦ Advancements in portable technologies, AI integration, and digital health platforms are enhancing accuracy, accessibility, and clinical decision-making.

✦ Additionally, increasing prevalence of chronic and infectious diseases, along with expanding healthcare access in emerging markets, will continue to drive strong demand.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/point-of-care-diagnostics-market?rs

United States Recent Developments:

✅ February 2026: Abbott Laboratories expanded its rapid point-of-care testing portfolio with new high-sensitivity assays for infectious diseases, strengthening decentralized diagnostics capabilities.

✅ January 2026: Danaher Corporation (via its diagnostics platform) introduced advanced portable diagnostic systems enabling faster clinical decision-making in emergency and outpatient settings.

✅ December 2025: Becton Dickinson enhanced its point-of-care diagnostic solutions with improved connectivity features for real-time data integration across healthcare networks.

Ready to scale in the Point of Care Diagnostics Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/point-of-care-diagnostics-market?rs

Partner Identification

✓Increase Your Customer Base by 3X using our Partner Identification tool
✓Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
✓Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
✓Prioritize partners by strategic fit rather than general capability.

List of Key Players 2026:

BD, QuidelOrtho Corporation, QIAGEN, Trinity Biotech plc, BioMérieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, and SEKISUI MEDICAL CO., LTD., among others.

Growth Forecast Projected 2026:

The Global Point of Care Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Key Developments 2025-2026:

✅ February 2026: Leading diagnostic companies expanded production capacity and strengthened supply chains to meet rising global demand for rapid and decentralized testing solutions.

✅ January 2026: Manufacturers introduced next-generation point-of-care devices with enhanced accuracy, faster turnaround times, and integration with digital health platforms for improved patient management.

✅ December 2025: Adoption of portable and home-based diagnostic solutions accelerated, driven by increasing demand for convenient, real-time health monitoring and chronic disease management.

✅ November 2025: Companies expanded partnerships and distribution networks across emerging markets in Asia-Pacific, Latin America, and the Middle East to improve accessibility to rapid diagnostics.

✅ October 2025: Investments in AI-enabled diagnostics and connectivity features advanced data analytics, remote monitoring, and clinical decision support in point-of-care testing systems.

How Our Market Research Process Works:

The global Point of Care Diagnostics Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Point of Care Diagnostics ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ March 2026: Activist investor Altai Capital Management pushed OraSure Technologies to explore a potential sale, signaling upcoming M&A activity in point-of-care diagnostics.

✅ March 2026: Agilent Technologies agreed to acquire Biocare Medical to strengthen pathology and diagnostic capabilities.

✅ February 2026: Danaher Corporation announced acquisition of Masimo to expand diagnostics portfolio.

Request Strategic Market Customization: https://datamintelligence.com/customize/point-of-care-diagnostics-market?rs

Japan Recent Developemnts

✅ February 2026: Sysmex Corporation developed next-generation point-of-care hematology analyzers designed for rapid and accurate blood testing in decentralized settings.

✅ January 2026: Fujifilm Holdings advanced portable diagnostic imaging and testing solutions to support early disease detection and remote healthcare delivery.

✅ December 2025: Terumo Corporation collaborated with healthcare providers to expand access to point-of-care diagnostic technologies, particularly in critical care and home settings.

Major Focused Key Segmentations 2026:

Product: Infectious Disease Testing Products, Blood Glucose Products, Blood Gas & Electrolyte Products, Hematology Testing Products, Urinalysis Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Profiling Products, Drug-of-Abuse Testing Products, Others

Technology: Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Microfluidics, Others

Application: Infectious Diseases, Hematology, Cardiology, Endocrinology, Oncology, Neurology, Drug Testing, Others

End User: Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgery Centers (ASCs), Home Care Settings

Regional Growth Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=point-of-care-diagnostics-market?rs

FAQ

Q1: What is the current size of the Point of Care Diagnostics Market?

A: Point of Care Diagnostics Market reached US$ 44.72 Billion in 2024 and is expected to reach US$ 106.35 Billion by 2033

Q2: How rapidly will the Market expanding?

A: The Point of Care Diagnostics market is projected to grow at a CAGR of 10.7% between 2025 and 2033.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/point-of-care-diagnostics-subscription?rs

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.